Consistent with these data, CREBBP-mutant lymphomas show reduced expression of genes that are antagonistically regulated by the BCL6-SMRT-HDAC3 complex and become dependent on HDAC3 for their survival. The gene discussed is CREBBP; the disease is lymphoma.